001     136090
005     20240228141002.0
024 7 _ |a 10.3389/fimmu.2015.00078
|2 doi
024 7 _ |a pmid:25759692
|2 pmid
024 7 _ |a pmc:PMC4338807
|2 pmc
024 7 _ |a altmetric:3781920
|2 altmetric
037 _ _ |a DKFZ-2018-00785
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Meister, Michael
|0 P:(DE-He78)aa3ff9fc2739d5cb7f822cbd7c1e39c9
|b 0
|e First author
|u dkfz
245 _ _ |a Dickkopf-3, a tissue-derived modulator of local T-cell responses.
260 _ _ |a Lausanne
|c 2015
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533198517_14047
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The adaptive immune system protects organisms from harmful environmental insults. In parallel, regulatory mechanisms control immune responses in order to assure preservation of organ integrity. Yet, molecules involved in the control of T-cell responses in peripheral tissues are poorly characterized. Here, we investigated the function of Dickkopf-3 in the modulation of local T-cell reactivity. Dkk3 is a secreted, mainly tissue-derived protein with highest expression in organs considered as immune-privileged such as the eye, embryo, placenta, and brain. While T-cell development and activation status in naïve Dkk3-deficient mice was comparable to littermate controls, we found that Dkk3 contributes to the immunosuppressive microenvironment that protects transplanted, class-I mismatched embryoid bodies from T-cell-mediated rejection. Moreover, genetic deletion or antibody-mediated neutralization of Dkk3 led to an exacerbated experimental autoimmune encephalomyelitis (EAE). This phenotype was accompanied by a change of T-cell polarization displayed by an increase of IFNγ-producing T cells within the central nervous system. In the wild-type situation, Dkk3 expression in the brain was up-regulated during the course of EAE in an IFNγ-dependent manner. In turn, Dkk3 decreased IFNγ activity and served as part of a negative feedback mechanism. Thus, our findings suggest that Dkk3 functions as a tissue-derived modulator of local CD4(+) and CD8(+) T-cell responses.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Papatriantafyllou, Maria
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Nordström, Viola
|0 P:(DE-He78)9bce4efcbedb17d7b4d0d7832c136faf
|b 2
|u dkfz
700 1 _ |a Kumar, Varun
|b 3
700 1 _ |a Ludwig, Julia
|0 P:(DE-He78)ef1ac16ab2fde9280b9c44dfed15848f
|b 4
|u dkfz
700 1 _ |a Lui, Kathy O
|b 5
700 1 _ |a Boyd, Ashleigh S
|b 6
700 1 _ |a Popovic, Zoran
|0 P:(DE-He78)659b67be544344052284c48f7d49c7cd
|b 7
|u dkfz
700 1 _ |a Fleming, Thomas Henry
|b 8
700 1 _ |a Moldenhauer, Gerhard
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Nawroth, Peter P
|b 10
700 1 _ |a Gröne, Hermann-Josef
|0 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
|b 11
|u dkfz
700 1 _ |a Waldmann, Herman
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Oelert, Thilo
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Arnold, Bernd
|0 P:(DE-He78)554abc2af2666cc3421cc0d7f6e7b6de
|b 14
|e Last author
|u dkfz
773 _ _ |a 10.3389/fimmu.2015.00078
|g Vol. 6
|0 PERI:(DE-600)2606827-8
|p 78
|t Frontiers in immunology
|v 6
|y 2015
|x 1664-3224
909 C O |o oai:inrepo02.dkfz.de:136090
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)aa3ff9fc2739d5cb7f822cbd7c1e39c9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)9bce4efcbedb17d7b4d0d7832c136faf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)ef1ac16ab2fde9280b9c44dfed15848f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)659b67be544344052284c48f7d49c7cd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)554abc2af2666cc3421cc0d7f6e7b6de
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT IMMUNOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b FRONT IMMUNOL : 2015
920 1 _ |0 I:(DE-He78)G130-20160331
|k G130
|l Zelluläre und Molekulare Pathologie
|x 0
920 1 _ |0 I:(DE-He78)D050-20160331
|k D050
|l Molekulare Immunologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G130-20160331
980 _ _ |a I:(DE-He78)D050-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21